Related Experiment Video

Updated: Jul 15, 2025

Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays
07:42

Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays

Published on: September 19, 2018

8.0K

Focal adhesion kinase: from biological functions to therapeutic strategies

Ximin Tan1, Yuheng Yan1, Bin Song2

  • 1Department of Oncology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.

Experimental Hematology & Oncology
|September 25, 2023
PubMed

Insights

Focal adhesion kinase (FAK) is crucial for cancer cell functions and tumor growth. Targeting FAK with inhibitors, especially in combination therapies, shows promise for cancer treatment, offering new therapeutic strategies.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • Focal adhesion kinase (FAK) is a nonreceptor tyrosine kinase essential for cell proliferation, survival, migration, and invasion.
  • FAK plays a significant role in regulating cancer stem cell activities and shaping the tumor microenvironment (TME).
  • Elevated FAK expression and activity correlate with poor prognosis and metastasis in various cancers.

Purpose of the Study:

  • To review the structure and function of FAK.
  • To summarize research progress on FAK inhibitors in combination cancer therapies.
  • To discuss challenges and future directions for anti-FAK combination therapies.

Main Methods:

  • Literature review of FAK structure, function, and inhibitor studies.
  • Analysis of preclinical data on FAK inhibitors in monotherapy and combination regimens.
  • Discussion of clinical implications and future research avenues.

Main Results:

  • FAK is a key regulator of cellular processes critical for cancer progression.
  • FAK inhibitors have demonstrated efficacy in preclinical cancer models, particularly in combination treatments.
  • Modulating FAK activity presents a viable therapeutic strategy for various malignancies.

Conclusions:

  • FAK is a promising therapeutic target in oncology.
  • Combination therapies involving FAK inhibitors offer enhanced efficacy for cancer treatment.
  • Further research is needed to overcome challenges and optimize anti-FAK combination strategies.
Keywords:
Combination therapyFocal adhesion kinaseImmunotherapyTumor microenvironment

More Related Videos

Impedance-based Real-time Measurement of Cancer Cell Migration and Invasion09:23

Impedance-based Real-time Measurement of Cancer Cell Migration and Invasion

Published on: April 2, 2020

6.5K
Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods07:49

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods

Published on: July 17, 2019

6.1K

Related Concept Videos

Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
2.7K
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
2.5K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
Cell Adhesion Molecules - Types and Functions01:20

Cell Adhesion Molecules - Types and Functions

Cell adhesion molecules (CAMs) are pivotal to multicellularity and the coordinated functioning of tissues and organ systems. They enable physical interactions between cells and provide mechanical strength to tissues. They also function as receptors for signal transmission across the plasma membrane. The CAMs are broadly classified into four families - integrins, cadherins, selectins, and immunoglobulin-like CAMs (IgCAMs).
CAM Families
The Integrin family of proteins is primarily  involved...
6.8K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.7K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
8.5K